About GenLight

Genlight develops a magnetic resonance-guided laser ablation system and an implantable closed-loop responsive neurostimulation system for the treatment of epilepsy and other neurological disorders. These technologies provide precise, minimally invasive interventions that monitor and stimulate neural activity, addressing the challenges of managing chronic neurological conditions.

```xml <problem> Epilepsy and other neurological disorders often require invasive surgical procedures or systemic drug therapies, which can lead to significant side effects and limited efficacy. Precise targeting of affected brain tissue remains a challenge, and real-time monitoring of neural activity is often lacking in traditional treatment approaches. </problem> <solution> Genlight develops and commercializes two innovative medical device systems for neurological disorders. The first is a magnetic resonance-guided laser ablation (MRgLITT) system designed for minimally invasive brain surgery, enabling precise ablation of targeted tissue under real-time MRI guidance. The second is an implantable closed-loop responsive neurostimulation (RNS) system that monitors and responds to neural activity in real-time, providing personalized and adaptive therapy for conditions like epilepsy and Parkinson's disease. Both systems aim to improve treatment outcomes while minimizing invasiveness and side effects. </solution> <features> - MRgLITT system with dual-wavelength laser and integrated water-cooled fiber optic catheter for precise and safe ablation. - MRgLITT system offers multiple fiber sizes and configurations for tailored ablation zones. - MRgLITT software suite integrates pre-operative planning, intra-operative monitoring, and post-operative assessment. - Implantable RNS system enables closed-loop monitoring and stimulation of neural activity for responsive therapy. - RNS system allows for full cranial implantation. - RNS system features high-sensitivity local field potential signal acquisition. - RNS system incorporates high-efficiency, low-heat wireless charging technology. </features> <target_audience> The primary target audience includes neurosurgeons, neurologists, and hospitals specializing in the treatment of epilepsy, Parkinson's disease, and other neurological disorders requiring precise surgical or neurostimulation interventions. </target_audience> ```

What does GenLight do?

Employees

9 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

GenLight

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

glightmed.com 100+

Funding

No funding information available.

Team (5+)

No team information available.

Company Description

Problem

Epilepsy and other neurological disorders often require invasive surgical procedures or systemic drug therapies, which can lead to significant side effects and limited efficacy. Precise targeting of affected brain tissue remains a challenge, and real-time monitoring of neural activity is often lacking in traditional treatment approaches.

Solution

Genlight develops and commercializes two innovative medical device systems for neurological disorders. The first is a magnetic resonance-guided laser ablation (MRgLITT) system designed for minimally invasive brain surgery, enabling precise ablation of targeted tissue under real-time MRI guidance. The second is an implantable closed-loop responsive neurostimulation (RNS) system that monitors and responds to neural activity in real-time, providing personalized and adaptive therapy for conditions like epilepsy and Parkinson's disease. Both systems aim to improve treatment outcomes while minimizing invasiveness and side effects.

Features

MRgLITT system with dual-wavelength laser and integrated water-cooled fiber optic catheter for precise and safe ablation.

MRgLITT system offers multiple fiber sizes and configurations for tailored ablation zones.

MRgLITT software suite integrates pre-operative planning, intra-operative monitoring, and post-operative assessment.

Implantable RNS system enables closed-loop monitoring and stimulation of neural activity for responsive therapy.

RNS system allows for full cranial implantation.

RNS system features high-sensitivity local field potential signal acquisition.

RNS system incorporates high-efficiency, low-heat wireless charging technology.

Target Audience

The primary target audience includes neurosurgeons, neurologists, and hospitals specializing in the treatment of epilepsy, Parkinson's disease, and other neurological disorders requiring precise surgical or neurostimulation interventions.